51 related articles for article (PubMed ID: 1791873)
1. Logistic multiple regression analysis of factors predicting recurrence of hyperthyroidism after medical treatment of toxic diffuse goitre.
de Rave S; Goldschmidt HM; Bravenboer B; Loosveld OJ; Lockefeer JH
Neth J Med; 1991 Oct; 39(3-4):131-5. PubMed ID: 1791873
[TBL] [Abstract][Full Text] [Related]
2. Prediction of remission after antithyroid drug treatment in Graves' disease.
Young ET; Steel NR; Taylor JJ; Stephenson AM; Stratton A; Holcombe M; Kendall-Taylor P
Q J Med; 1988 Feb; 66(250):175-89. PubMed ID: 2902655
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum triiodothyronine and thyroxine concentrations in hyperthyroidism.
de Rave S; Bravenboer B; Loosveld OJ; Lockefeer JH; Goldschmidt HM
Neth J Med; 1993 Feb; 42(1-2):48-52. PubMed ID: 8446224
[TBL] [Abstract][Full Text] [Related]
4. Prediction of outcome in Graves' disease after carbimazole treatment.
Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM
Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
[TBL] [Abstract][Full Text] [Related]
7. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
El Refaei SM; Shawkat W
Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
[TBL] [Abstract][Full Text] [Related]
8. Remission of Grave's disease after oral anti-thyroid drug treatment.
Ishtiaq O; Waseem S; Haque MN; Islam N; Jabbar A
J Coll Physicians Surg Pak; 2009 Nov; 19(11):690-3. PubMed ID: 19889263
[TBL] [Abstract][Full Text] [Related]
9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
10. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease.
Schott M; Morgenthaler NG; Fritzen R; Feldkamp J; Willenberg HS; Scherbaum WA; Seissler J
Horm Metab Res; 2004 Feb; 36(2):92-6. PubMed ID: 15002058
[TBL] [Abstract][Full Text] [Related]
11. Once daily, low dose, short term antithyroid drug treatment of Graves' disease is followed by an unacceptably high relapse rate.
Ford HC; Feek CM; Delahunt JW
N Z Med J; 1991 Mar; 104(907):97-8. PubMed ID: 2006072
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
13. Remission of Graves' hyperthyroidism treated with methimazole.
Bolaños F; González-Ortiz M; Durón H; Sánchez C
Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
[TBL] [Abstract][Full Text] [Related]
14. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
Schumm-Draeger PM
Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
[TBL] [Abstract][Full Text] [Related]
15. Predictor of outcome of hyperthyroidism due to Graves disease: serum triiodothyronine/thyroxine ratio.
Khanna CM; Shankar LR; Jaggi CB; Bansal JK; Chugh P
J Assoc Physicians India; 1996 Feb; 44(2):98-101. PubMed ID: 10999059
[TBL] [Abstract][Full Text] [Related]
16. [Recurrence of Graves-Basedow disease: the influence of treatment schedule].
Goñi Iriarte MJ; Forga Llenas L; Iriarte Beroiz A; Apiñániz EA; Rodríguez Erdozain R; Menéndez Torre E
Med Clin (Barc); 1995 Jan; 104(1):11-4. PubMed ID: 7877347
[TBL] [Abstract][Full Text] [Related]
17. Hyperthyroidism.
Maji D
J Indian Med Assoc; 2006 Oct; 104(10):563-4, 566-7. PubMed ID: 17380820
[TBL] [Abstract][Full Text] [Related]
18. Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment.
Kaguelidou F; Alberti C; Castanet M; Guitteny MA; Czernichow P; Léger J;
J Clin Endocrinol Metab; 2008 Oct; 93(10):3817-26. PubMed ID: 18628515
[TBL] [Abstract][Full Text] [Related]
19. Hormonal pattern of relapse in hyperthyroidism.
Marsden P; Chalkley S; Leatherdale B; Howorth PJ; Acosta M; McKerron CG
Lancet; 1975 Apr; 1(7913):944-7. PubMed ID: 48121
[TBL] [Abstract][Full Text] [Related]
20. Relapse after short-term antithyroid therapy of Graves' disease.
Burr WA; Fitzgerald MG; Hoffenberg R
N Engl J Med; 1979 Jan; 300(4):200. PubMed ID: 581607
[No Abstract] [Full Text] [Related]
[Next] [New Search]
